Robert Mollen’s Post

At Spring Science, we're harnessing the power of specialized AI models to revolutionize drug discovery. Our mission is to accelerate the development of life-changing treatments by compressing years of biomedical progress into a fraction of the time. Imagine a future where complex diseases are tackled more efficiently, where potential therapies are identified faster, and where the path from lab to patient is dramatically shortened. This isn't science fiction - it's the reality we're building at Spring Science. Our AI-powered platform is designed to analyze vast amounts of biological data, uncovering insights that might take traditional methods decades to discover. We're not just improving drug discovery; we're reimagining it. Stay tuned as we share more about our innovative approach and its potential to transform healthcare. The future of medicine is here, and it's driven by AI. #AIinHealthcare #DrugDiscovery #BiomedicalInnovation

Two posts in a row! What can I say? Yesterday was an intense day at BiteLabs Healthtech's Healthcare Technology and Innovation Fellowship! In the evening, we had a fascinating workshop on Artificial Intelligence in Healthtech. We had the pleasure of having: 🔹 Keith Grimes (Digital Health Consultant at Curistica, former Principal Product Manager for AI at Babylon) 🔹 Annabelle Painter (Medical Director at Visiba Care and Clinical AI Fellow) Special thanks to Keith, who stayed an hour longer to share his recommendations on prompt engineering 🤗. I wanted to share his interpretation of Tesler’s Theorem, ‘The AI Effect,’ in relation to medicine: ‘𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗶𝘀 𝘄𝗵𝗮𝘁𝗲𝘃𝗲𝗿 𝗺𝗮𝗰𝗵𝗶𝗻𝗲𝘀 𝗰𝗮𝗻’𝘁 𝗱𝗼 𝘆𝗲𝘁.’ We live in an era of technological advancement and a shortage of healthcare professionals. It’s inevitable that AI and technology will try to fill this gap. The question is: if technology can outperform doctors, what is their role? Medicine is becoming that unique thing that machines are not able to do, such as human connection. At least for the time being. What are your thoughts? I would love to know!

Looking forward to go back to Zurich tomorrow for the Outsourcing Clinical Trial DACH Conference Can't wait to learn and connect with industry leaders and innovators. As the chair of Day 2, I'll be moderating exciting sessions on the latest trends in clinical trials. And that's not all! Join me on Day 1 for an interactive panel presentation, "United for Progress: AI and Emerging Technologies Shaping the Future". Want to join the conversation? Get ready to participate in this hands-on session. Happy to connect with you as well on LinkedIn or at any point during the conference. Let's shape the future of clinical trials together! #OCTDACH #ClinicalTrials #AI #PharmaInnovation #EmergingTech #Outsourcing2Win

Continuing on during Day 3 of #InnovationDublin24 is “How AI Impacts the Sector” panel moderated by Elisabeth Marrache, Partner, at Addleshaw Goddard: • Manuela Finger, Partner, Addleshaw Goddard • Jenny Fitzgerald, Chief Experience Officer, Deciphex   • Miao He, PhD MBA, Senior Investment Associate, Hadean Ventures • Helen Stewart, Director, New Product Development, IQVIA • Fionn Lahart, Co-Founder & Chief Executive Officer, LUMA Vision Key takeaways: • AI holds great promise for better patient diagnoses and monitoring, for example, working in epilepsy, the advanced diagnostic platform of Neuro Event Labs, which automates the analysis of video and audio recordings from a patient’s bedside. • The medtech industry is at an inflection point for the adoption of AI, and new regulation is providing clarity around the right approaches to take. • Good processes for harnessing and QC’ing data inputs are necessary for reliable AI. Deciphex is amassing its own quality datasets tagged, manually and with the help of AI, with the right diagnostic codes. • Despite the cost of data, and data processing capabilities, the small companies are probably best placed to bring novel AI solutions to the traditional companies Remain informed on new articles, conference updates and more with our helpful #medtech community newsletter. Subscribe here: https://bit.ly/42KHJKI

A very dynamic panel discussion that I thoroughly enjoyed. It was great to hear various perspectives on AI in Medtech and how it intersects with the evolving regulatory landscape. Looking forward to seeing how these discussions shape the future of innovation in the Medtech industry. #digitalinnovation #AImedtech #digitalpathology

📣 AI – A Game Changer for the Future of Nordic Life Sciences Join our panel of Biotech Leaders as they discuss: ·  How AI is revolutionizing the drug discovery process in the Nordic life sciences sector ·  The role of AI in advancing precision medicine and personalized healthcare initiatives across the Nordic region - how are AI algorithms enhancing patient outcomes, while ensuring a tailored approach to individual health needs? ·  The ethical considerations surrounding the use of AI in life science. How are Nordic countries addressing concerns related to data privacy, security, and the responsible deployment of AI technologies? ·  Collaborative efforts and knowledge exchange platforms that facilitate the integration of AI in Nordic life sciences. How can we harness the full potential of AI, and what lessons can be shared with the global scientific community? 🎙 Hear from: ·  Paul Ainsworth, Director, Sterne, Kessler, Goldstein & Fox ·  Mala Valroy, Investment Manager, Industrifonden ·  Julie Klint, Director, Head of Molecular Discovery & Enabling Technologies, Lundbeck ·  Hisham Hamadeh, SVP, Global Head of Data Science & AI, Genmab · Daniel Schmidt, Co-founder & Partner, Biobridge Partners Find out more: https://lnkd.in/eMvhAE4U #LSXNordic #Biotech

The word is out, the next edition of Science for Health will focus on AI, data, and digitalization. Mark your calendars for November 12th!

📆 SAVE THE DATE for Science for health – at SQUARE Brussels on 12 November 2024 – the event where biology meets technology! This year's edition will be all about AI, Data & Digitalization💡🧬🦾   We’ll examine how these tools can accelerate innovation in Drug Discovery & Development and Prevention & Diagnostics. With world-class speakers, international case studies, and a collaborative round table, we’ll discuss how AI, Data & Digitalization can help revolutionizing the healthcare of today and tomorrow 🚀   Science for health brings together academics, industry leaders and policymakers to promote out-of-the-box thinking, tackle complex challenges, and spark new research collaborations. Every past edition has been sold out, with over 300 people uniting to form connections in Belgium and beyond. These collaborations help shape the future of healthcare, tackling current challenges and building a brighter future for all!   Get inspired and join forces: save the date today!   👉 https://lnkd.in/eY7GXtFf   #sfh2024 #biotech #medtech #healthinnovation #AI #bigdata #digitalhealth MEDVIA BioWin - The Health Cluster of Wallonia

On 21st February I will be presenting at the TMC AI Summit in Houston (Texas Medical Center). The summit will be on 20th and 21st of that month. I will be talking about challenges when implementing predictive models at an academic medical center, and some solutions. The presentation will focus on how to build useful models that match the clinical decision making process, how to sustain model monitoring and update when the research grant that funded initial development runs out, getting access to data and how to deal with small datasets, and more.

11 weeks to go until our LSX USA Congress takes place in Boston (11th-12th Sept)! We're excited to showcase the exciting panels and world class speakers we have confirmed. First up... 📣 Defining our AI Future – Operationalising AI to Deliver Business & Patient Benefits Join our panel of #HealthtechLeaders as they discuss: 📌Barriers to adoption so we can build out scale with AI 📌The bridge between commercial and R&D 📌Maintaining the human touch - How can we use AI to improve the patient experience? 📌What are the safeguards for applications of AI? 📌AI use in Pharma- Analytics, leveraging RWE, AI modelling and increasing efficiency & effectiveness 🎙 Hear from: 🎤Alexandra Gonçalves, MD, MMSc, PhD, VP, Head of Digital Health, Bristol Myers Squibb 🎤Shweta Maniar, Global Director Health & Life Sciences, Google 🎤 Ziv Bar-Joseph, VP, Head, R&D Data and Computational Sciences, Sanofi 🎤Amir Zur, Executive Director, Head of R&D Digital Head Products, Former Takeda 🎤Andreas Cleve, CEO, Corti Find out more: https://bit.ly/4eEbT9j #LSXUSA #Healthtech #digitalhealth #AI